Siddharth Reddy

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 438 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

Raches Ella, Siddharth Reddy, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 365 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Risk factors for stillbirths: how much can a responsive health system prevent?

Sutapa Bandyopadhyay Neogi, Jyoti Sharma, Preeti Negandhi et al. · BMC Pregnancy and Childbirth · 2018 · 58 citations · Full text

Public Health, Maternal Health, Obstetrics +17

Persisting antibody responses to Vi polysaccharide–tetanus toxoid conjugate (Typbar TCV®) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination

Krishna Mohan Vadrevu, Dugyala Raju, Sandhya Rani et al. · Vaccine · 2021 · 42 citations · Full text

Medicine, Immunology, Pediatrics +17

Effects of glucose and blood pressure control on complications of type 2 diabetes mellitus

Christian Nasr, B J Hoogwerf, Charles Faiman et al. · Cleveland Clinic Journal of Medicine · 1999 · 38 citations

Medicine, Endocrinology, Pharmacotherapy +17